International Biotechnology (LON:IBT – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 656.71 ($8.64) and traded as high as GBX 690 ($9.07). International Biotechnology shares last traded at GBX 674 ($8.86), with a volume of 41,424 shares trading hands.
International Biotechnology Price Performance
The stock has a fifty day moving average of GBX 677.82 and a two-hundred day moving average of GBX 656.71. The stock has a market cap of £247.59 million, a price-to-earnings ratio of 1,404.17 and a beta of 0.21. The company has a quick ratio of 0.32, a current ratio of 0.46 and a debt-to-equity ratio of 9.66.
International Biotechnology Increases Dividend
The business also recently declared a dividend, which was paid on Friday, August 23rd. Stockholders of record on Thursday, July 25th were paid a dividend of GBX 14.50 ($0.19) per share. The ex-dividend date of this dividend was Thursday, July 25th. This is a boost from International Biotechnology’s previous dividend of $13.90. This represents a dividend yield of 2.28%. International Biotechnology’s dividend payout ratio is 6,041.67%.
Insider Activity at International Biotechnology
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
See Also
- Five stocks we like better than International Biotechnology
- How to Choose Top Rated Stocks
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- With Risk Tolerance, One Size Does Not Fit All
- Introduction to Fibonacci Retracement Levels
- Industrial Products Stocks Investing
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.